Ignite Creation Date:
2025-12-24 @ 7:48 PM
Ignite Modification Date:
2026-03-16 @ 10:02 AM
Study NCT ID:
NCT01858103
Status:
APPROVED_FOR_MARKETING
Last Update Posted:
2014-04-02
First Post:
2013-05-15
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
BMN 110 US Expanded Access Program
Sponsor:
BioMarin Pharmaceutical
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
110-503
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None